The University Hospital

Dr. med. Benjamin Ruf

Dr. med. Benjamin Ruf

Physician in residency & Research group leader

Physician in residency in the Department of Internal Medicine I

Research group leader at the M3 Research Center (https://www.medizin.uni-tuebingen.de/de/das-klinikum/einrichtungen/zentren/m3/tumor-immune-microenvironment)

MINT-CS Clinician Scientist

  • 04/2011 - 12/2017
    Medical School at Eberhard Karls University Tübingen, Germany; King’s College London and University of Aberdeen (U.K.)
  • 12/2017
    License to practice medicine
  • 12/2017
    Doctoral thesis (Dr. med.) on the topic "Combination of the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus as a new option for epi-virotherapeutic treatment of hepatocellular carcinoma" (summa cum laude))
  • 01/2018 - 06/2019
    Residency in Internal Medicine (focus on gastroenterology, gastrointestinal oncology, hepatology & infectiology), Department of Internal Medicine I, Tübingen University Medical Center
  • 06/2019 - 06/2023
    Postdoctoral Research Fellow, Tim Greten's Lab, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, USA.
  • seit 07/2023
    Residency in Internal Medicine (focus on gastroenterology, gastrointestinal oncology, hepatology & infectiology), Department of Internal Medicine I, Tübingen University Medical Center
  • seit 07/2023
    Research group leader at the M3 Research Center Tübingen
  • 10/2023
    Associate Member - Cluster of Excellence 2180 "Image-guided and Functionally Instructed Tumor Therapies" (iFIT)
  • 07/2024
    German Research Foundation-funded Clinician Scientist Program 'Medical Innovation through Interdisciplinarity' (MINT-CS)
  • German Society for Gastroenterology,Digestive and Metabolic Diseases (DGVS)
  • Society for Immunotherapy of Cancer (SITC)
  • The International Liver Cancer Association (ILCA)
  • American Association for Cancer Research (AACR)
  • German Society for Immunology (DGfI)